Regular mammograms linked to longer survival in women over 80
For many older women, the question of whether to continue breast cancer screening has been uncertain. While most…
Reticulocalbin-1 in clear cell renal cell carcinoma: clinical and functional evidence for its role as a biomarker and potential therapeutic target | BMC Cancer
Despite therapeutic advancements, the prognosis for metastatic ccRCC remains poor, with a 5-year survival rate of approximately 12–20…
Preventing radiation damage with melanin-based material
 Radiotherapy for abdominal and pelvic cancers almost always leads to small-intestine injuries that are difficult to heal,…
Study identifies immune biomarkers for personalized therapies in pediatric germ cell tumors
A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos…
Multi-modal characterization of metabolic and immune gene clusters in adrenocortical carcinoma treatment
Establishment of the TIME subtype According to recent literature, knowledge of the TIME should be the main emphasis…
Casdatifan/Cabozantinib Shows Efficacy in Pretreated ccRCC
Casdatifan in combination with cabozantinib (Cabometyx) generated responses and was associated with a manageable safety profile in patients…
Expanding Patient Access to Comprehensive Genomic Profiling
Comprehensive genomic profiling (CGP) is reshaping cancer care by enhancing diagnostic accuracy, informing prognosis, and enabling more personalized…
Early ctDNA Status May Guide Consolidation Immunotherapy for Limited-Stage SCLC
Credit: Deep AI Measuring circulating tumor (ct) DNA after induction chemotherapy could identify the best candidates for consolidation…
What Is Cancer Cachexia? Causes, Symptoms, Diagnosis, and Treatment
IntroductionPathophysiology of cancer cachexiaClinical features and symptomsPrevalence and clinical impactDiagnosis and stagingManagement strategiesChallenges and research directionsConclusionsReferencesFurther reading Cancer…